These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19733126)

  • 21. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
    Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
    Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sector analysis provides additional spatial information on the permanent prostate brachytherapy learning curve.
    Mohamed Yoosuf AB; Mitchell DM; Workman G; Jonnada S; Napier E; Jain S
    Brachytherapy; 2015; 14(5):703-10. PubMed ID: 26123653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL.
    Dallas NL; Malone PR; Jones A; Doggart AJ; McConway KJ; Rogers PB
    BJU Int; 2012 Aug; 110(3):383-90. PubMed ID: 22332791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer.
    Pinkawa M; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2006 Sep; 182(9):525-30. PubMed ID: 16944374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.
    Bittner N; Wallner K; Merrick G; Orio P; Nurani R; True L
    Am J Clin Oncol; 2008 Jun; 31(3):231-6. PubMed ID: 18525300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.
    Patil N; Crook J; Saibishkumar EP; Aneja M; Borg J; Pond G; Ma C
    Brachytherapy; 2009; 8(2):218-222. PubMed ID: 19230790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
    Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
    Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term rectal function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
    Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P; von Borczyskowski DW; Henkel T; Rosner C; Graf R; Tilly W; Budach V; Felix R; Kahmann F
    Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Reed DR; Wallner KE; Narayanan S; Sutlief SG; Ford EC; Cho PS
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):301-7. PubMed ID: 16111600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.
    Pinkawa M; Berneking V; König L; Frank D; Bretgeld M; Eble MJ
    Strahlenther Onkol; 2017 Jan; 193(1):22-28. PubMed ID: 27632342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.